Literature DB >> 64382

Bovine leukemia virus: an exogenous RNA oncogenic virus?

R Kettmann, D Portetelle, M Mammerickx, Y Cleuter, D Dekegel, M Galoux, J Ghysdael, A Burny, H Chantrenne.   

Abstract

Short term cultures of bovine leukemic lymphocytes release virus particles with biochemical properties of RNA oncogenic viruses. These particles, tentatively called Bovine Leukemia Virus (BLV) have a high molecular weight-reverse transcriptase complex and a density averaging 1.155 g/ml in sucrose solutions. Molecular hybridizations between BLV-3H cDNA and several viral RNAs show that BLV is not related to Mason-Pfizer Monkey Virus (MPMV) Simian Sarcoma Associated Virus (SSV-1) Feline Leukemia Virus (FeLV) or Avian Myeloblastosis Virus (AMV). Rauscher Leukemia Virus (RLV) exhibits a slight but reproducible relatednesse to BLV. The high preference of BLV reverse transcriptase for Mg++ as the divalent cation suggests that BLV might be an atypical mammalian leukemogenic type C virus. Hybridization studies using BLV 3H cDNA as a probe suggest that the DNA of bovine leukemic cells contains viral sequences that cannot be detected in normal bovine DNA.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 64382     DOI: 10.1007/978-3-642-87524-3_37

Source DB:  PubMed          Journal:  Hamatol Bluttransfus        ISSN: 0440-0607


  2 in total

1.  Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: implications for viral latency.

Authors:  C Merezak; C Pierreux; E Adam; F Lemaigre; G G Rousseau; C Calomme; C Van Lint; D Christophe; P Kerkhofs; A Burny; R Kettmann; L Willems
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Kinetics of Bovine leukemia virus aspartic protease reveals its dimerization and conformational change.

Authors:  Martín Fló; Federico Carrión; Natalia Olivero-Deibe; Sergio Bianchi; Madelón Portela; Florencia Rammauro; Beatriz Alvarez; Otto Pritsch
Journal:  PLoS One       Date:  2022-07-22       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.